|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM349785929 |
| 003 |
DE-627 |
| 005 |
20240907232331.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1007/s00289-022-04579-3
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1526.xml
|
| 035 |
|
|
|a (DE-627)NLM349785929
|
| 035 |
|
|
|a (NLM)36466080
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Ait Hamdan, Youssef
|e verfasserin
|4 aut
|
| 245 |
1 |
4 |
|a The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 07.09.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status Publisher
|
| 520 |
|
|
|a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
|
| 520 |
|
|
|a In 2020, Coronavirus disease (COVID-19), a new viral respiratory disease caused by a virus that belongs to Coronaviridae family, has been identified. It is a very severe flu that negatively affects the functions of the lung and other respiratory organs. COVID-19 virus can be transmitted between people either by touching an infected person or by direct contact with their respiratory droplets. Therefore, the COVID-19 virus has become a global concern due to its rapid spread and severity. Based on the World Health Organization report from 2 March 2020 to 24 October 2022, the total infected cases and deaths in Morocco are around 1,265,389 (3.46%) and 16,280 (0.04%), respectively. Recently, some scientists have found that chitosan, a polymer existed in nature, can inhibit COVID-19 infection and repair damaged tissue. Therefore, understanding chitosan mechanisms in controlling COVID-19, might lead to innovative strategies in the medical field, such as developing drugs against SARS-CoV-2, and replacing vaccines, which have negative side effects. This review aims to show the evolution of the COVID-19 pandemic worldwide, specifically in Morocco, its pathophysiology, and its ability to silence the immune system. This review also provides an overview of the treatments and measures applied to protect human beings and how chitosan acts and controls COVID-19
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Aminopolysaccharide
|
| 650 |
|
4 |
|a Coronavirus
|
| 650 |
|
4 |
|a Death
|
| 650 |
|
4 |
|a Health
|
| 650 |
|
4 |
|a Recovery
|
| 650 |
|
4 |
|a Vaccines
|
| 700 |
1 |
|
|a El Amerany, Fatima
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Desbrières, Jacques
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Aghrinane, Abdessadek
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Oudadesse, Hassane
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Rhazi, Mohammed
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Polymer bulletin (Berlin, Germany)
|d 1998
|g (2022) vom: 21. Nov., Seite 1-27
|w (DE-627)NLM098152874
|x 0170-0839
|7 nnns
|
| 773 |
1 |
8 |
|g year:2022
|g day:21
|g month:11
|g pages:1-27
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/s00289-022-04579-3
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2022
|b 21
|c 11
|h 1-27
|